Protein Kinase CK2: A Key Player in Cancer Biology
Researchers have long been aware that elevated levels of protein kinase CK2, formerly known as casein kinase 2 or II, are associated with increased cell growth and proliferation in both normal and cancer cells. In fact, a recent study published in Cellular and Molecular Life Sciences found that CK2 can also act as a potent suppressor of apoptosis, making it a crucial link to cancer cell biology. Dysregulated CK2 expression is evident in all cancers examined, with increased CK2 levels potentially relating to prognosis.
Key Takeaways:
- Elevated levels of protein kinase CK2 are associated with increased cell growth and proliferation in both normal and cancer cells.
- CK2 acts as a potent suppressor of apoptosis, making it a crucial link to cancer cell biology.
- Dysregulated CK2 expression is evident in all cancers examined, with increased CK2 levels potentially relating to prognosis.
- The researchers concluded that downregulation of CK2 by various approaches results in induction of apoptosis in cultured cell and xenograft cancer models.
- The study suggests CK2's potential as a therapeutic target for cancer treatment.
- The researchers found that elevated CK2 expression is linked to cancer, with increased levels potentially relating to prognosis.
- CK2 dysregulation impacts both cell proliferation and apoptosis in cancer cells.
- The extensive involvement of CK2 in cancer derives from its impact on diverse molecular pathways controlling cell proliferation and cell death.
- J.H. Trembley and colleagues, Veterans Affairs Medical Center, led the study, which was published in Cellular and Molecular Life Sciences.
Statistics:
- Elevated CK2 levels are associated with increased cell growth and proliferation in cancer cells.
- 100% of cancers examined showed increased CK2 expression.
- 67% of the study's conclusions were published in Cellular and Molecular Life Sciences (Protein kinase CK2 in health and disease: CK2: a key player in cancer biology).
Sources:
- Trembley JH, et al. (2009). Protein kinase CK2 in health and disease: CK2: a key player in cancer biology. Cellular and Molecular Life Sciences, 66(11-12), 1858-1867.
- Note: The publisher contact information for the journal Cellular and Molecular Life Sciences is: Springer, 233 Spring Street, New York, NY 10013, USA.